Sunday, September 13, 2026

China’s Atlantic Amsterdam Platform Moves: What This Means for Sino-Korean Relations?

China is relocating its maritime platform Atlantic Amsterdam from the Korea-China Provisional Measures Zone, easing tensions with South Korea.

L&K Biomed’s BlueX-C: First Clinical Success in the U.S. Spine Implant Market!

L&K Biomed's BlueX-C cervical cage achieves FDA approval and successful clinical application, signaling strong market potential in the U.S.

USPEER Teases Bold Debut – Can They Match Oh My Girl’s Success?

WM Entertainment introduces USPEER, a new girl group, marking their first in 10 years, promising unique sound and captivating performances.

Tag: facility

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Is BTGEN the Next Big Player in Biopharmaceuticals? Discover Their Unique CDMO Strategy

BTGEN is expanding its CDMO business with National Growth Fund support, focusing on innovative processes instead of competing on scale.

M.I. Tech Launches New Manufacturing Plant in Vietnam: What This Means for Global Medical Device Supply Chains

M.I. Tech opens a new production facility in Vietnam to enhance its global supply chain and meet rising demand for medical devices.

Daewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures

Daewoong Pharmaceutical hosted the "Nabota Master Class" for 74 medical professionals from 13 countries, focusing on safety and clinical application.

Celltrion’s Strategic Move: How Local Production in the U.S. Can Mitigate Tariff Risks

Celltrion outlines its Branchburg facility's operations and plans to mitigate tariff risks by establishing local production and a supply system.

How Celltrion is Tackling U.S. Tariff Risks with New Production Facility in 2026

Celltrion addresses tariff risks by acquiring a U.S. facility, ensuring product supply and implementing strategies to mitigate uncertainties.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.